Results

Total Results: 722 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
    May 29, 2025 - "Sleep'time" blood"pressure"as"a"therapeutic"target"for"cardiovascular"risk"reduction"in"type"2"diabetes … Sleep'time"ambulatory"blood"pressure"as"a"novel"therapeutic"target"for" cardiovascular"risk"reduction … Home"blood"pressure"and"cardiovascular"outcomes"in"patients"during" antihypertensive"therapy:"primary"results"of"HONEST … Efficacy" and"safety"of"aliskiren"and"amlodipine"combination"therapy"in"patients"with"hypertension:" … received$home$BP$telemonitors$and$transmitted$BP$data$to$pharmacists$who$adjusted$ antihypertensive$therapy
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
    August 01, 2013 - Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … Research for CER 119, “Treatment of Atrial Fibrillation,” focusing on the treatment of AF through rate … There are also many novel invasive treatments for AF. … , and strategies for determining longer term therapy given successful AF treatment … continued anticoagulant therapy versus bridging therapies versus interruption of therapy (i.e., stopping
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
    April 01, 2014 - Medicare beneficiaries with both medical and psychiatric conditions likely experi- ences complexity in treatment … The Medicare drug benefit (Part D) and treatment of heart failure in older adults. … Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries … Partnerships/downloads/11522-P.pdf Data Points • #19 • Medication Use in Medicare 14 Appendix A: Part D therapeutic … Antiparkinson agents Central nervous system agents Antianxiety agents Neuromuscular drugs Musculoskeletal therapy
  4. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … this intervention for treating AD and amnestic MCI.10 Various insulin products already approved for diabetes … Experts commenting on this intervention agreed that the need for disease-modifying treatments for AD … adoption: Experts anticipated that the drug’s well-known safety profile and long history of use (in diabetes … Insulin: compare common options for insulin therapy. [internet].
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
    July 01, 2012 - Rapidly Evolving Tests A third challenge, especially relevant to medical tests, is that, even more than treatments … Time from results to treatment not reported. … Both conditions are associated with risk of type II diabetes. … Treatment Trends As therapeutics arise that change the course of disease and modify outcomes, literature … ., people with arthritis, women, obese patients) or setting (e.g., primary care practice, physical therapy
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - gain, elevated lipids and prolactin levels, and have been associated with the development of type 2 diabetes … adverse events include: • Mortality • Cerebrovascular disease-related events • Development of diabetes … • Major adverse events: mortality, cerebrovascular disease-related events, development of diabetes … age, sex, race, weight, height, body mass index, co-morbidities, use of concurrent standard medical therapies … Phenothiazines/ad, to, tu, ct, po, ae [Administration & Dosage, Toxicity, Therapeutic Use, Contraindications
  7. effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
    January 01, 2012 - Alternative Treatments Comparison of a treatment with a clinically meaningful alternative treatment … and glitazones for diabetes, and are not commonly used off-label for other conditions, the indication … analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics … Hormone replacement therapy and cardiovascular health in the United States. Med Care. … Cancer risk in patients with rheumatoid arthritis treated with anti–tumor necrosis factor a therapies
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
    March 01, 2016 - The comorbid conditions of interest include cardiovascular disease, hypertension, type-2 diabetes, obesity … onset and progression of chronic diseases of aging, including cardiovascular disease, hypertension, diabetestreatments, is also not well elucidated. … For assessing the effectiveness and safety of treatments for co-occurring diseases or risk factors, … Treatment of substance misuse in older women: using a brief intervention model.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - While biologic treatments may represent a treatment option with fewer adverse effects, there are concerns … plaque psoriasis who are candidates for systemic therapy or phototherapy when other therapies are … TNF-α Treatment of severe chronic plaque psoriasis in adults who are candidates for systemic therapy … failed to respond to at least one systemic therapy or in patients for whom other systemic therapies … and treatment of meningeal leukemia; used alone or in combination therapy in the treatment of breast
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf
    November 01, 2014 - object is to help consumers, health care providers, and others in making informed choices among treatment … Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … patient (i.e., a systematic process of collecting patient-specific information, assessing medication therapies … substitution issue; complex regimen that can be simplified with same therapeutic benefit; and potential … for hypertension and dyslipidemia Insufficient for treatment of patients with diabetes, depression
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
    June 15, 2016 - (including self-initiated therapies), and treatment duration or intensity? … (including self-initiated therapies), and treatment duration or intensity? … o Physical treatments and/or weight loss § Physical therapy and exercise programs • Manual therapy … Stem cell therapy trials will not have high applicability as this treatment is currently limited in … Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/autoimmune-disease-rapid-research.pdf
    November 01, 2024 - A class of therapeutic agents called DMARDs (disease-modifying anti-rheumatic drugs) has been in use … or even a mix of both therapy types. … Most of the included studies had patients who were on either therapy or even a mix of both therapy types … .78 The reductions in PASI scores at 3-6 months post-NSPT may be considered half as effective as a therapeutic … Set# Searched for # Results S21 S20 NOT (TI,AB(cancer* OR neoplasm* OR malignan* OR tumo$r* OR diabetes
  13. 13-MDM347013 30..38 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
    January 01, 2009 - may extend into the longer term.11 A randomized trial of blood glucose self-monitoring among type 2 diabetes … perceptions or illness cognitions have been shown to affect adherence behavior among patients with HIV, diabetes … Clinicians use tests to increase their diagnostic and therapeutic confidence. … Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON … How do patients’ treatment preferences compare with those of clinicians?
  14. 13-MDM347013 30..38 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
    January 01, 2009 - may extend into the longer term.11 A randomized trial of blood glucose self-monitoring among type 2 diabetes … perceptions or illness cognitions have been shown to affect adherence behavior among patients with HIV, diabetes … Clinicians use tests to increase their diagnostic and therapeutic confidence. … Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON … How do patients’ treatment preferences compare with those of clinicians?
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pressure-ulcer-prevention_research-protocol.pdf
    January 10, 2012 - By one estimate, treatment costs may be as much as 2.5 times the cost of prevention. 1 A number of … impairment; body weight; nutritional status; incontinence; or specific medical comorbidities, such as diabetes … age, race or skin tone, physical impairment, body weight, or specific medical comorbidities (e.g., diabetes … www.effectivehealthcare.ahrq.gov Published Online: January 10, 2012 6 comorbidities (e.g., diabetes … Waterlow pressure ulcer prevention/treatment policy card. Revised 2005.
  16. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research-2014.pdf
    January 01, 2014 - purposes for patient registries include evaluating the safety, effectiveness, or quality of medical treatments … Examples of outcome measures Title Definition Type Response to rituximab treatment Reduction of … For example, an important outcome measure in diabetes care is management of HbA1c. … Members 18 - 75 years of ages with diabetes. … Patient French AutoImmunity and Rituximab (AIR) Registry Response to rituximab treatment, as measured
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_research-protocol.pdf
    April 03, 2014 - Treatment options are not limited to psychological and behavioral therapies and pharmacologic interventions … Aroma therapy Bright-light therapy Brief behavioral therapy Biofeedback Cognitive behavioral therapy … cognitive behavioral therapy and drug therapy) for the treatment of insomnia disorder in adults? … What are the harms of combined treatments (e.g. cognitive behavioral therapy and drug therapy) for insomnia … Cognitive Behavioral Therapy for Insomnia in Older Adults: Background, Evidence, and Overview of Treatment
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_protocol-140716.pdf
    April 03, 2014 - Treatment options are not limited to psychological and behavioral therapies and pharmacologic interventions … Aroma therapy Bright-light therapy Brief behavioral therapy Biofeedback Cognitive behavioral therapy … cognitive behavioral therapy and drug therapy) for the treatment of insomnia disorder in adults? … What are the harms of combined treatments (e.g. cognitive behavioral therapy and drug therapy) for insomnia … Cognitive Behavioral Therapy for Insomnia in Older Adults: Background, Evidence, and Overview of Treatment
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
    September 01, 2014 - baseline target from which to go forward and randomize treatments. … What about harms associated with intensive statin therapy such as diabetes or rhabdomyolysis What … For example, intensive statin therapy has been associated with an increased risk of diabetes compared … Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.JAMA … In addition to therapeutic lifestyle changes, a moderate or high dose of a statin therapy should be
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
    February 01, 2009 - Diabetes was defined by the presence of diagnoses plus use of anti-diabetic medications. … Discussion In this study of over 20,000 elderly patients initiating APM treatments, use of conventional … Clin Therapeutics 2002;24(9):1466-76. 5. Chan YC, Pariser SF, Neufeld G. … arrhythmia 1.4 1.4 Cerebrovascular disease 29.1 30.9 CHF 32.6 31.1 Diabetes … *Controlled for calendar year, age, gender, race, prior arrhythmias, cerebrovascular disease, CHF, diabetes

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: